Video Shorts

0:53
Alexander Drilon, MD, Discusses Human Touch in Cancer Care
3 days ago
by
Alexander Drilon, MD

0:53
Learning Korean at BTG Lung in Seoul!
5 days ago
by
Byoung Chul Cho, MD, PhD

1:35
What's One Thing Your Patients Have Taught You?
6 days ago
by
Chris Grant, MD

1:44
Human Touch in Cancer Care
7 days ago
by
Riley Kandel(+1 more)

1:38
SOHO 2026 RECAP
8 days ago
by
Riley Kandel(+1 more)

1:04
Treatment for Locally Advanced Stage IIIA, ALK+ NSCLC
8 days ago
by
Stephen Liu, MD

1:16
Spotlighting Best Practices for NSCLC Staging and Management
8 days ago
by
Karine Tawagi, MD(+1 more)

1:14
Highlighting the Importance of Individualized Breast Cancer Screening Practices
9 days ago
by
Sara Nunnery, MD, MSCI(+1 more)

2:18
Ranking Novel MPN Treatments at SOHO 2026
9 days ago
by
Andrew Kuykendall, MD(+1 more)

0:26
Catch OncLive On the Ground at SOHO and WCLC 2026!
11 days ago
by
Riley Kandel

1:20
Noting ILD/Radiation Pneumonitis Outcomes From DESTINY-Breast05
17 days ago
by
Charles E. Geyer, MD

1:13
Exploring Mavorixafor in Chronic Neutropenia Management
18 days ago
by
David Sykes, MD, PhD

1:33
Selecting a JAK Inhibitor in Myelofibrosis
18 days ago
by
Aaron Gerds, MD, MS

1:36
Spotlighting the Importance of Biomarker Testing in GI Cancer
19 days ago
by
Midhun Malla, MD

1:38
Highlighting Appendix Cancer Awareness Month
19 days ago
by
Philip A. Philip, MD

1:01
Examining Amivantamab in Head and Neck Cancer
20 days ago
by
Ranee Mehra, MD

0:41
Comparing Mechanisms of Action for BTK Degraders and Inhibitors
23 days ago
by
Zulfa Omer, MD

1:19
Highlighting a Phase 3 Trial of Ozuriftamab Vedotin in HPV-Associated OPSCC
23 days ago
by
Alan L. Ho, MD, PhD

0:52
Individualizing Efforts to Lower Recurrence Risk in Breast Cancer
23 days ago
by
Sara Nunnery, MD, MSCI(+1 more)

1:13
Unpacking Data for Shorter Venetoclax Schedules in AML
23 days ago
by
Uma Borate, MBBS, MS

1:15
Highlighting Radioligand Therapies in GEP-NETs
24 days ago
by
Andrew E. Hendifar, MD

0:47
Emphasizing the Importance of Biomarkers in Head and Neck Cancer
24 days ago
by
Fangdi Sun, MD

0:39
Spotlighting the Efficacy and Safety of Atebimetinib-Based Therapy in Pancreatic Cancer
24 days ago
by
Daniel H. Ahn, DO

0:51
How Does Optune Pax Work in Pancreatic Cancer?
24 days ago
by
Andrew Ko, MD

0:45
Highlighting the Efficacy of Daraxonrasib in Pancreatic Cancer
24 days ago
by
Shubham Pant, MD, MBBS

0:46
Exploring Unmet Needs in Head and Neck Cancer
25 days ago
by
Dan Zandberg, MD

1:30
What Is the Mechanism of Action of the Newly Approved Daraxonrasib for PDAC?
25 days ago
by
Kim A. Reiss Binder, MD

1:05
What Are the Next Steps for Darlifarnib Plus Cabozantinib in RCC?
a month ago
by
Adanma Ayanambakkam, MD, MS

1:00
Predicting How Today's FDA Approval of Zanidatamab Will Affect Gastric Cancer Care
a month ago
by
Zev A. Wainberg, MD

0:43
What Does the RASolute 302 Trial Mean for Pancreatic Cancer Care?
a month ago
by
Paul E. Oberstein, MD
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Imlunestrant Plus Abemaciclib for ER+, HER2–, ESR1-Mutated Metastatic Breast Cancer
2
Tumor-Reactive TIL and UMIS Biomarker Predict Response in Metastatic Uveal Melanoma
3
Dr Gilbert on the Efficacy of Relacorilant Plus Nab-Paclitaxel in Ovarian Cancer
4
EU Approval Reccomended by CHMP for Senaparib in First-Line Advanced Ovarian Cancer
5
